Publication | Open Access

Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer

Cancer ImmunosurveillanceAutoimmune DiseaseCheckpoint InhibitorsMedicineImmunologyTumor ImmunityPathologyImmune Checkpoint InhibitorAutoimmunityRheumatoid ArthritisImmunologic DiseasePre-existing Autoimmune DiseaseImmunotherapyOncologyImmune-related Adverse EventsCancer Research